SoVarGen Co.

PharmaceuticalsSeries BDaejeon, South Koreasovargen.com

Latest round

Series B

Last raised

Sep 2020

Total raised

$38M

Investors

13

About SoVarGen Co.

, Ltd. is a pharmaceutical company specializing in drug research and development for central nervous system (CNS) diseases., Ltd.

Who invested in SoVarGen Co.

13 investors across 2 rounds

See all investors in SoVarGen Co.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Sep 3, 2020

    Amount

    $29M

    Investors

    Locked

  2. Series A

    Oct 26, 2018

    Amount

    $8.8M

    Investors

    Locked

Questions about SoVarGen Co.

Who invested in SoVarGen Co.?

SoVarGen Co. has 13 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has SoVarGen Co. raised?

SoVarGen Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did SoVarGen Co. last raise money?

SoVarGen Co.'s most recent round on record is a Series B, in Sep 2020.

What does SoVarGen Co. do?

SoVarGen Co. is a pharmaceuticals company.

Where is SoVarGen Co. headquartered?

SoVarGen Co. is headquartered in Daejeon, South Korea.

Which VCs invest in companies like SoVarGen Co.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at SoVarGen Co.'s stage. Their profiles are linked below.

Raising like SoVarGen Co.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.